About Processa
Processa is a company based in Hanover (United States) founded in 2011 by Sian Bigora, Wendy Guy, and David Young.. The company has 10 employees as of December 31, 2024. Processa operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others.
- Headquarter Hanover, United States
- Employees 10 as on 31 Dec, 2024
- Founders Sian Bigora, Wendy Guy, David Young
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Processa Pharmaceuticals, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-11.85 M-6.55as on Dec 31, 2024
-
EBITDA
$-12.05 M-5.18as on Dec 31, 2024
-
Latest Funding Round
$10.24 M (USD), Post-IPO
Feb 17, 2021
-
Investors
-
Employee Count
10
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Processa
Processa is a publicly listed company on the NASDAQ with ticker symbol PCSA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Processa
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $10.2M
-
First Round
First Round
(22 May 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Post-IPO - Processa | Valuation |
investors |
|
| Jun, 2018 | Amount | Post-IPO - Processa | Valuation |
investors |
|
| May, 2018 | Amount | Post-IPO - Processa | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Processa
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Processa
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Processa Comparisons
Competitors of Processa
Processa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Processa
Frequently Asked Questions about Processa
When was Processa founded?
Processa was founded in 2011 and raised its 1st funding round 7 years after it was founded.
Where is Processa located?
Processa is headquartered in Hanover, United States. It is registered at Hanover, New Hampshire, United States.
Who is the current CEO of Processa?
David Young is the current CEO of Processa. They have also founded this company.
How many employees does Processa have?
As of Dec 31, 2024, the latest employee count at Processa is 10.
What does Processa do?
Founded in 2011 and based in Hanover, United States, Processa operates in the pharmaceutical sector with a focus on small molecule development. The lead candidate, PCS499, a deuterated analog of pentoxifyllines major metabolite, is under investigation in Phase 2 trials for Necrobiosis Lipoidica, a necrotizing skin condition. The same compound is also being evaluated for managing radiation therapy side effects in head and neck cancer patients.
Who are the top competitors of Processa?
Processa's top competitors include Moderna, Spark Therapeutics and BridgeBio.
Is Processa publicly traded?
Yes, Processa is publicly traded on NASDAQ under the ticker symbol PCSA.
What is Processa's ticker symbol?
The ticker symbol of Processa is PCSA on NASDAQ.